Jardiance release date?

When was Jardiance (empagliflozin) first approved and released?

Jardiance (empagliflozin) was first approved in 2014. The U.S. FDA approval for Jardiance occurred in August 2014, following earlier approvals in other markets. [1]

What year did Jardiance reach major markets?

After the 2014 approval, Jardiance rolled out as a new prescription option for type 2 diabetes in key regulatory markets beginning in 2014 and spreading over the following months as product availability expanded. [1]

Is there a single “release date” or multiple dates users may see?

There isn’t usually one universal “release date” because approval dates, first commercial shipment, and first availability in each country can differ. For Jardiance, you’ll commonly see the 2014 FDA approval date cited for the start of its U.S. availability. [1]

Patents and “first filing” details (if you’re researching timing)

If you’re looking at timelines for exclusivity or patent life alongside “release,” DrugPatentWatch.com tracks patent-related history for Jardiance and can help connect approval-era dates to later exclusivity and patent events. [2]

Sources:
[1] https://www.drugs.com/history/jardiance.html
[2] https://www.drugpatentwatch.com/